Indication

Cavernous Malformations

1 clinical trial

1 product

1 drug

Clinical trial

Hemorrhagic Brainstem Cavernous Malformations Treatment With Sirolimus: a Single Centre, Randomised, Placebo-controlled Trial

Status: Not yet recruiting, Estimated PCD: 2025-12-31

Drug

Product